Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-013917
Filing Date
2025-04-30
Accepted
2025-04-30 17:28:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A allr20250430_defa14a.htm DEFA14A 9790
2 notice01.jpg GRAPHIC 322027
3 notice02.jpg GRAPHIC 465993
  Complete submission text file 0001437749-25-013917.txt   1095939
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41160 | Film No.: 25897680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)